Skip to content

The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke

The Influence of Mandibular Advancement Device Treating OSAHS on Primary Prevention of Ischemic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03665818
Enrollment
100
Registered
2018-09-11
Start date
2016-07-09
Completion date
2019-12-31
Last updated
2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Carotid Plaque, Sleep Apnea Syndromes

Brief summary

1. The purpose of this study is to detect the differences of carotid atherosclerosis severity between patients with or without OSAHS(Obstructive Sleep Apnea and Hypopnea Syndrome) in a cross-sectional study in a large sample. 2. Then a longitudinal control study is conducted to observe the progress of the carotid atherosclerosis by vascular ultrasonography and the occurrence of cerebrovascular events after the intervention of the oral appliance for treating OSAHS,and finally explore the feasibility of using oral appliance to treat OSAHS in primary prevention of ischemic stroke.

Detailed description

1. the relevance of OSAHS and carotid atherosclerosis Patients are distributed questionnaire and recruited from neurology clinic,vascular ultrasonography clinic of Xuanwu Hospital if they match the inclusion criteria. After initial screening, carotid atherosclerosis patients with skeptical OSAHS are sent to sleep center for polysomnography examination to determine the severity of OSAHS. At least 50 patients for mild, moderate, severe OSAHS each are recruited for OSAHS Group. At least 100 patients without snoring from questionnaire and without OSAHS after PSG screening are recruited for non OSAHS Group. Vascular ultrasonography examination for carotid are done for the two groups. Data of carotid vascular plaque from two groups are collected. Statistics are done to detect differences of carotid atherosclerosis severity between patients with and without OSAHS, also the severity of OSAHS. 2. the relevance of the progress of carotid atherosclerosis and oral appliances intervention for treating OSAHS All carotid atherosclerosis patients with OSAHS are from patients of the first study. If they consent the treatment of oral appliances, they are recruited into this second study. At least 100 patients are recruited. They are divided into 2 groups by randomized block design by Evidence-based Medicine Center of Xuanwu Hospital. One group is oral appliance intervention group, the other group is no intervention group. The intervention group patients accept oral appliance treatment, and no intervention group patients do not accept OSAHS treatment. The two groups both accept anti-hypertension treatment or anti-diabetes treatment, or anti-hyperlipidemia treatment according to their own situation in neurology clinic. At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the intervention group should accept PSG(Polysomnography) examination to monitor the treatment of OSAHS. At timepoint of initial time, one month after oral appliance treatment, one and a half year after oral appliance treatment, the two groups should accept breath holding test to monitor the cerebral vascular reserve. At timepoint of initial time, one and a half year after oral appliance treatment, the two groups should accept carotid vascular ultrasonography examination to monitor the progress of carotid atherosclerosis. Cerebrovascular events and death are recorded from initial time. Statistics are done to detect the influence of treatment of OSAHS on carotid atherosclerosis.

Interventions

DEVICEoral appliance treatment

mandibular advancement device to enlarge pharyngeal airway space to get rid of apnea and hypopnea events

Sponsors

Xuanwu Hospital, Beijing
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diagnosed with atherosclerosis by vascular ultrasonography * diagnosed with OSAHS by polysomnography

Exclusion criteria

* patients who have stroke already * patients who can not wear oral appliances according to experiment requirements * patients who have bad periodontal condition or teeth number less than 20

Design outcomes

Primary

MeasureTime frameDescription
apnea hypopnea events 0 in Timesinitial time when patients are recruitedapnea and hypopnea times per hour
apnea hypopnea events 1 in Timesone month after oral appliance treatmentapnea and hypopnea times per hour
apnea hypopnea events 2 in Timesone and a half years after oral appliance treatmentapnea and hypopnea times per hour
longest apnea time 0 in Secondsinitial time when patients are recruitedlongest apnea or hypopnea time
longest apnea time 1 in Secondsone month after oral appliance treatmentlongest apnea or hypopnea time
longest apnea time 2 in Secondsone and a half years after oral appliance treatmentlongest apnea or hypopnea time
Blood oxygen saturation less than 90% of the total monitoring time percentage 0 in percentageinitial time when patients are recruitedBlood oxygen saturation less than 90% of the total monitoring time percentage
Blood oxygen saturation less than 90% of the total monitoring time percentage 1 in percentageone month after oral appliance treatmentBlood oxygen saturation less than 90% of the total monitoring time percentage
Blood oxygen saturation less than 90% of the total monitoring time percentage 2 in percentageone and a half years after oral appliance treatmentBlood oxygen saturation less than 90% of the total monitoring time percentage
lowest Oxygen Saturation 0 in percentageinitial time when patients are recruitedblood lowest oxygen saturation during the whole night
lowest Oxygen Saturation 1 in percentageone month after oral appliance treatmentblood lowest oxygen saturation during the whole night
lowest Oxygen Saturation 2 in percentageone and a half years after oral appliance treatmentblood lowest oxygen saturation during the whole night
atherosclerosis plaque thickness 0 in common carotid artery in milimetreinitial time when patients are recruitedatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque thickness 1 in common carotid artery in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque length 0 in common carotid artery in milimetreinitial time when patients are recruitedatherosclerosis plaque length is distance from the beginning to the end of a separate plaque
atherosclerosis plaque length 1 in common carotid artery in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque length is distance from the beginning to the end of a separate plaqu
atherosclerosis plaque thickness 0 in internal carotid artery in milimetreinitial time when patients are recruitedatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque thickness 1 in internal carotid artery in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque thickness 0 in carotid bulb in milimetreinitial time when patients are recruitedatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque thickness 1 in carotid bulb in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque thickness is distance from the most convex point of plaque to carotid media
atherosclerosis plaque length 0 in internal carotid artery in milimetreinitial time when patients are recruitedatherosclerosis plaque length is distance from the beginning to the end of a separate plaque
atherosclerosis plaque length 1 in internal carotid artery in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque length is distance from the beginning to the end of a separate plaque
atherosclerosis plaque length 0 in carotid bolb in milimetreinitial time when patients are recruitedatherosclerosis plaque length is distance from the beginning to the end of a separate plaque
atherosclerosis plaque length 1 in carotid bolb in milimetreone and a half years after oral appliance treatmentatherosclerosis plaque length is distance from the beginning to the end of a separate plaque
breath holding index 0 in percentage/secondsinitial time when patients are recruitedbreath holding index = (v2-v1)/v2\*100/t. v2 is average velocity of middle cerebral artery after breath holding, v1 is average velocity of middle cerebral artery before breath holding, t is time for breath holding.
End systolic velocity of common carotid artery 0 in cm/sinitial time when patients are recruitedthe velocity of common carotid artery at the end of systolic period
End systolic velocity of common carotid artery 1 in cm/sone and a half years after oral appliance treatmentthe velocity of common carotid artery at the end of systolic period
End systolic velocity of internal carotid artery 0 in cm/sinitial time when patients are recruitedthe velocity of internal carotid artery at the end of systolic period
End systolic velocity of internal carotid artery 1 in cm/sone and a half years after oral appliance treatmentthe velocity of internal carotid artery at the end of systolic period
End systolic velocity of carotid bulb 0 in cm/sinitial time when patients are recruitedthe velocity of carotid bulb at the end of systolic period
End systolic velocity of carotid bulb 1 in cm/sone and a half years after oral appliance treatmentthe velocity of carotid bulb at the end of systolic period
end diastolic velocity of common carotid artery 0 in cm/sinitial time when patients are recruitedthe velocity of common carotid artery at the end of diastolic period
end diastolic velocity of common carotid artery 1 in cm/sone and a half years after oral appliance treatmentthe velocity of common carotid artery at the end of diastolic period
end diastolic velocity of internal carotid artery 0 in cm/sinitial time when patients are recruitedthe velocity of internal carotid artery at the end of diastolic period
end diastolic velocity of internal carotid artery 1 in cm/sone and a half years after oral appliance treatmentthe velocity of internal carotid artery at the end of diastolic period
end diastolic velocity of carotid bulb 0 in cm/sinitial time when patients are recruitedthe velocity of carotid bulb at the end of diastolic period
end diastolic velocity of carotid bulb 1 in cm/sone and a half years after oral appliance treatmentthe velocity of carotid bulb at the end of diastolic period

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026